XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Redeemable Noncontrolling Interest and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Equity Grants
IPO
Class A and Class B Common Stock
Class A and Class B Common Stock
Equity Grants
Class A and Class B Common Stock
IPO
Additional Paid-In Capital
Additional Paid-In Capital
Equity Grants
Additional Paid-In Capital
IPO
Accumulated Other Comprehensive Loss
Accumulated Deficit
Redeemable Noncontrolling Interest
Convertible Preferred Stock
Convertible Preferred Stock
Convertible Preferred Stock
Convertible Preferred Stock
IPO
Balance at beginning of period at Dec. 31, 2020                       $ 309    
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Net loss                       (54)    
Balance at end of period at Mar. 31, 2021                       255    
Balance at beginning of period (in shares) at Dec. 31, 2020       226,364,401                 109,090,908  
Balance at beginning of period at Dec. 31, 2020 $ (158,545)     $ 7     $ 453,655     $ 604 $ (1,012,400)   $ 399,589  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stock issued in connection with equity awards (in shares)       1,232,156                    
Stock issued in connection with equity awards 10,143           10,143              
Repurchases of stock (in shares)       (214,509)                    
Stock-based compensation 29,667           29,667              
Other comprehensive loss, net (721)                 (721)        
Net loss (10,521)                   (10,521)      
Balance at end of period (in shares) at Mar. 31, 2021       227,382,048                 109,090,908  
Balance at end of period at Mar. 31, 2021 (129,977)     $ 7     493,465     (117) (1,022,921)   $ 399,589  
Balance at beginning of period at Dec. 31, 2020                       309    
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Net loss (149)                          
Balance at end of period at Sep. 30, 2021                       160    
Balance at beginning of period (in shares) at Dec. 31, 2020       226,364,401                 109,090,908  
Balance at beginning of period at Dec. 31, 2020 (158,545)     $ 7     453,655     604 (1,012,400)   $ 399,589  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss 4,080                          
Balance at end of period (in shares) at Sep. 30, 2021       373,641,135                 0  
Balance at end of period at Sep. 30, 2021 2,049,059     $ 11     3,084,928     (27,560) (1,008,320)   $ 0  
Balance at beginning of period at Mar. 31, 2021                       255    
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Net loss                       (59)    
Balance at end of period at Jun. 30, 2021                       196    
Balance at beginning of period (in shares) at Mar. 31, 2021       227,382,048                 109,090,908  
Balance at beginning of period at Mar. 31, 2021 (129,977)     $ 7     493,465     (117) (1,022,921)   $ 399,589  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stock issued in connection with equity awards (in shares)       1,020,588                    
Stock issued in connection with equity awards 5,190           5,190              
Repurchases of stock (in shares)       (390,000)                    
Exercise of warrants, net of shares withheld (in shares)       6,229,081                    
Issuance of Class A common stock in connection with acquisitions (in shares)       6,320,688                    
Issuance of Class A common stock in connection with acquisitions 342,170           342,170              
Issuance of Class A common stock (in shares)       12,006                    
Issuance of Class A common stock in connection with initial public offering, net of issuance costs as adjusted for cost reimbursement (in shares)       22,500,000                    
Issuance of Class A common stock in connection with initial public offering, net of issuance costs as adjusted for cost reimbursement 1,747,971     $ 1     1,747,970              
Conversion of preferred stock to common stock in connection with initial public offering (in shares)           109,090,908               (109,090,908)
Conversion of preferred stock to common stock in connection with initial public offering     $ 0     $ 3     $ 399,586         $ (399,589)
Stock-based compensation 26,852           26,852              
Other comprehensive loss, net (9,188)                 (9,188)        
Net loss 14,423                   14,423      
Balance at end of period (in shares) at Jun. 30, 2021       372,165,319                 0  
Balance at end of period at Jun. 30, 2021 1,997,441     $ 11     3,015,233     (9,305) (1,008,498)   $ 0  
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Net loss (36)                     (36)    
Balance at end of period at Sep. 30, 2021                       160    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stock issued in connection with equity awards (in shares)         991,787                  
Stock issued in connection with equity awards   $ 7,782           $ 7,782            
Issuance of Class A common stock in connection with acquisitions (in shares)       405,205                    
Issuance of Class A common stock in connection with acquisitions 25,000           25,000              
Issuance of Class A common stock (in shares)       78,824                    
Issuance of Class A common stock 2,503           2,503              
Stock-based compensation 34,410           34,410              
Other comprehensive loss, net (18,255)                 (18,255)        
Net loss 178                   178      
Balance at end of period (in shares) at Sep. 30, 2021       373,641,135                 0  
Balance at end of period at Sep. 30, 2021 2,049,059     $ 11     3,084,928     (27,560) (1,008,320)   $ 0  
Balance at beginning of period at Dec. 31, 2021 201                     201    
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Net loss                       (41)    
Balance at end of period at Mar. 31, 2022                       160    
Balance at beginning of period (in shares) at Dec. 31, 2021       375,089,360                 0  
Balance at beginning of period at Dec. 31, 2021 2,138,090     $ 11     3,160,487     (45,454) (976,954)   $ 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stock issued in connection with equity awards (in shares)       1,179,554                    
Stock issued in connection with equity awards 6,541           6,541              
Shares withheld related to net share settlement (in shares)       (89,319)                    
Shares withheld related to net share settlement (4,227)           (4,227)              
Repurchases of stock - repurchase program (in shares)       (893,556)                    
Repurchases of stock - repurchase program (43,697)           (43,697)              
Stock-based compensation 44,377           44,377              
Other comprehensive loss, net (13,532)                 (13,532)        
Net loss (115,257)                   (115,257)      
Balance at end of period (in shares) at Mar. 31, 2022       375,286,039                 0  
Balance at end of period at Mar. 31, 2022 2,012,295     $ 11     3,163,481     (58,986) (1,092,211)   $ 0  
Balance at beginning of period at Dec. 31, 2021 201                     201    
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Net loss (201)                          
Balance at end of period at Sep. 30, 2022 0                     0    
Balance at beginning of period (in shares) at Dec. 31, 2021       375,089,360                 0  
Balance at beginning of period at Dec. 31, 2021 2,138,090     $ 11     3,160,487     (45,454) (976,954)   $ 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net loss (113,234)                          
Balance at end of period (in shares) at Sep. 30, 2022       371,649,578                 0  
Balance at end of period at Sep. 30, 2022 1,881,902     $ 11     3,112,224     (140,145) (1,090,188)   $ 0  
Balance at beginning of period at Mar. 31, 2022                       160    
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Net loss                       (51)    
Balance at end of period at Jun. 30, 2022                       109    
Balance at beginning of period (in shares) at Mar. 31, 2022       375,286,039                 0  
Balance at beginning of period at Mar. 31, 2022 2,012,295     $ 11     3,163,481     (58,986) (1,092,211)   $ 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stock issued in connection with equity awards (in shares)       1,194,805                    
Stock issued in connection with equity awards 8,267           8,267              
Shares withheld related to net share settlement (in shares)       (234,412)                    
Shares withheld related to net share settlement (9,384)           (9,384)              
Repurchases of stock - repurchase program (in shares)       (5,749,856)                    
Repurchases of stock - repurchase program (210,830)           (210,830)              
Issuance of Class A common stock in connection with acquisitions (in shares)       2,579,692                    
Issuance of Class A common stock in connection with acquisitions 137,422           137,422              
Issuance of common stock under employee stock purchase plan (in shares)       107,781                    
Issuance of common stock under employee stock purchase plan 3,663           3,663              
Stock-based compensation 56,855           56,855              
Other comprehensive loss, net (69,365)                 (69,365)        
Net loss (21,748)                   (21,748)      
Balance at end of period (in shares) at Jun. 30, 2022       373,184,049                 0  
Balance at end of period at Jun. 30, 2022 1,907,175     $ 11     3,149,474     (128,351) (1,113,959)   $ 0  
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Net loss (109)                     (109)    
Balance at end of period at Sep. 30, 2022 0                     $ 0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stock issued in connection with equity awards (in shares)       1,360,814                    
Stock issued in connection with equity awards 6,293           6,293              
Shares withheld related to net share settlement (in shares)       (149,015)                    
Shares withheld related to net share settlement (3,996)           (3,996)              
Repurchases of stock - repurchase program (in shares)       (2,746,270)                    
Repurchases of stock - repurchase program (84,353)           (84,353)              
Stock-based compensation 44,806           44,806              
Other comprehensive loss, net (11,794)                 (11,794)        
Net loss 23,771                   23,771      
Balance at end of period (in shares) at Sep. 30, 2022       371,649,578                 0  
Balance at end of period at Sep. 30, 2022 $ 1,881,902     $ 11     $ 3,112,224     $ (140,145) $ (1,090,188)   $ 0